Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)
Clinical trial NCT04817540 · RECRUITING
Trial details
- NCT number
- NCT04817540
- Sponsor
- Gangnam Severance Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-03-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.